SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : Bill Wexler's Dog Pound -- Ignore unavailable to you. Want to Upgrade?


To: DanZ who wrote (4292)10/9/1999 4:04:00 PM
From: Mad2  Read Replies (3) | Respond to of 10293
 
Dense? Old arguments that I lost on???? Last April you touted the NEJM thingy. Well sounds like thats down the toilet so you pooh pooh the significance of it not happening.
By the way Dan....your the argumentive one. I asked two questions with stated reasons and what you provide is opinion after opinion after opinion......much of which contradicts you expert and dilligent assessment offered 6 months ago of why GUMM was so great a buy.
The only thing different between QGLY and GUMM is you don't own QGLY stock and you do own GUMM. The fact that GUMM is grossly overvalued in comparison to QGLY escapes your comprehension, which is why you think GUMM is such a get deal.
Time to short GUMM again (gotta call my real broker as most online firms dont deal in this one), the NEJM silver bullit never left the barrel. Can't wait to digest the next few Q's comming out of GUMM.....all those coop $$ they will have spent to try and sell a nasel squirt gun.....wasted capital.
I can't even find the stuff having looked at 3 Walgreen's. Even if it was there it's a trick to find anything given the numerous products available.
Mad2



To: DanZ who wrote (4292)10/9/1999 4:23:00 PM
From: mike devage  Read Replies (1) | Respond to of 10293
 
"To the gentleman that is smiling and laughing. Consumers spent ~$2.5 billion on OTC cold remedies last year that only mask symptoms and don't reduce the duration of the cold. How much will they spend on a product that eliminates the cold in about 2 days? That has me smiling too."

Mr Zimmerman, I wish you well and I have no position in this equity, but if 2.5 billion is the market for OTC cold remedies don't you think the pharmecuticals would buy up GUMM and either market the product or put it on the shelf in the back room ala the oil companies with alternative energy.

Still smiling

Mike